title: Patient relapse in the context of drug abuse treatment.
abstract: How do addiction treatment programs integrate the expectation of relapse into drug abuse treatment? This article serves as a thought piece to pose questions rather than definitive solutions. It reflects a distillation of discussions that occurred at the National Institute on Drug Abuse meeting titled "Program Response to Patient Relapse," held on July 15, 2009, along with quantitative and qualitative information about the patterns and types of discharge policies, which factors influence them, and how the culture of drug abuse treatment and the personnel interact with this issue. Some existing data on the discharging of relapsed patients are identified. A program's response to relapse is usually guided by its setting (level of care), philosophy (abstinence vs risk behavior reduction), and associated patient behavior ("benign" vs program disruptive). Key questions examined in this context include the following: Can different discharge policies impact a patient's access to treatment, and what are the implications of incorporating a medical model of addiction into discharge policies?
authors.affiliation: National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
authors.forename: Timothy P
authors.initials: TP
authors.lastname: Condon
authors.forename: Petra
authors.initials: P
authors.lastname: Jacobs
authors.forename: Betty
authors.initials: B
authors.lastname: Tai
authors.forename: Denise
authors.initials: D
authors.lastname: Pintello
authors.forename: Lucinda
authors.initials: L
authors.lastname: Miner
authors.forename: Jennifer C
authors.initials: JC
authors.lastname: Elcano
mesh_terms: D006801:Humans; D010351:Patient Discharge / Q000639:trends; D010352:Patient Dropouts; D017410:Practice Guidelines as Topic; D012008:Recurrence; D019966:Substance-Related Disorders / Q000534:rehabilitation / Q000628:therapy*; D016896:Treatment Outcome; D014481:United States